LogoLogo
  • Technology
  • Events
  • Company
Products
AestheticsVision
Technology
Resources
WebinarsClinical PublicationsPhysician TestimonialsNewsFAQs
Events
Company
Find a clinic
SearchSearchFind a clinicFind a clinic
Search
Products
AestheticsVision
Technology
Resources
WebinarsClinical PublicationsPhysician TestimonialsNewsFAQs
Events
Company
Find a clinic
SearchSearchFind a clinicFind a clinic
Search
Products
AestheticsVision
Technology
Resources
WebinarsClinical PublicationsPhysician TestimonialsNewsFAQs
Events
Company
Find a clinic
Novoxel® Reaffirms Tixel’s Industry-Leading Safety Record

Novoxel® Reaffirms Tixel’s Industry-Leading Safety Record

Editorial
November 18, 2025
1 minute

Novoxel® Reaffirms Tixel’s Industry-Leading Safety Record

Following the U.S. Food and Drug Administration’s recent safety warning regarding radiofrequency (RF) microneedling devices, Novoxel, the manufacturer of Tixel, is reaffirming the distinct safety and technology advantages of its proprietary Thermo-Mechanical Action (TMA) technology.

Thermo-Mechanical Action (TMA®) Is Not RF Microneedling

Read Full Article

Logo

Discover Tixel® powered by TMA® technology. Revolutionary fractional skin resurfacing with maximum safety, minimal side effects. Quick, effective treatments for aesthetic and dry eye applications.

Support
  • Get Support
  • Request a Demo
Product
  • Aesthetics
  • Vision
Company
  • About the Company
  • Contact Us
  • Events
Resources
  • News
  • Webinars
  • Clinical Publications
  • FAQs
  • Testimonials
Legal
  • Intellectual Property
  • Counterfeit Devices Warning
Regulation
  • Quality Assurance
  • Regulatory Updates

Product

  • Aesthetics
  • Vision

Company

  • About the Company
  • Contact Us
  • Events

Resources

  • News
  • Webinars
  • Clinical Publications
  • FAQs
  • Testimonials

Support

  • Get Support
  • Request a Demo

Legal

  • Intellectual Property
  • Counterfeit Devices Warning

Regulation

  • Quality Assurance
  • Regulatory Updates

Newsletter

Stay updated with our latest Tixel news.

© 2026 Tixel®, Novoxel®, and TMA®. All rights reserved.

Privacy policyCookie preferences